首页> 外文OA文献 >Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors vs Conventional Chemotherapy in Non–Small Cell Lung Cancer Harboring Wild-Type Epidermal Growth Factor Receptor

【2h】

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors vs Conventional Chemotherapy in Non–Small Cell Lung Cancer Harboring Wild-Type Epidermal Growth Factor Receptor

机译：表皮生长因子受体酪氨酸激酶抑制剂与含有野生型表皮生长因子受体的非小细胞肺癌常规化疗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
June-Koo Lee; Seokyung Hahn; Dong-Wan Kim; Koung Jin Suh; Bhumsuk Keam; Tae Min Kim; Se-Hoon Lee; Dae Seog Heo;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Epidermal growth factor receptor tyrosine kinase inhibitors vs conventional chemotherapy in non-small cell lung cancer harboring wild-type epidermal growth factor receptor: A meta-analysis [J] . LeeJ.-K., HahnS., KimD.-W., JAMA: the Journal of the American Medical Association . 2014,第14期

机译：表皮生长因子受体酪氨酸激酶抑制剂与非小细胞肺癌的常规化疗，含有野生型表皮生长因子受体：META分析
2. Epidermal growth factor receptor tyrosine kinase inhibitors vs conventional chemotherapy in non-small cell lung cancer harboring wild-type epidermal growth factor receptor: A meta-analysis [J] . LeeJ.-K., HahnS., KimD.-W., JAMA: the Journal of the American Medical Association . 2014,第14期

机译：表皮生长因子受体酪氨酸激酶抑制剂与常规化学疗法治疗非小细胞肺癌野生型表皮生长因子受体的荟萃分析
3. The Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer Harboring Wild-type Epidermal Growth Factor Receptor: A Meta-analysis of 25 RCTs [J] . Sheng Zhixin, Zhang Yanxia American Journal of Clinical Oncology: Cancer Clinical Trials . 2017,第4期

机译：表皮生长因子受体酪氨酸激酶抑制剂在含有野生型表皮生长因子受体的非小细胞肺癌中的疗效：25 rcts的Meta分析
4. The Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor ZD1839 (Iressa) Suppresses Proliferation and Invasion of Human Oral Squamous Carcinoma Cells via p53 Independent and MMP, uPAR Dependent Mechanism [C] . EUN JU LEE, JIN HA WHANG, NAM KYEONG JEON, Meeting on Cell Signaling World: Signal Transduction Pathways as Therapeutic Targets . 2007

机译：表皮生长因子受体酪氨酸激酶抑制剂ZD1839（Iressa）通过独立于p53和MMP，uPAR依赖性机制抑制人口腔鳞状细胞癌细胞的增殖和侵袭
5. Unanticipated Effects of Tyrosine Kinase Inhibitors on Vitamin D Receptor Expression and Gene Regulation In Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer. [D] . Timberlake, Alexandra F. 2017

机译：酪氨酸激酶抑制剂对表皮生长因子受体突变的非小细胞肺癌中维生素D受体表达和基因调控的意外影响。
6. The Efficacy and Safety of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Combined With Thymosin in Advanced Non-Small Cell Lung Cancer Patients Harboring Active Epidermal Growth Factor Receptor Mutations [O] . Yongdong Feng, Guangkuo Zhu, Song Lang, 2021

机译：表皮生长因子受体酪氨酸激酶抑制剂与患有活性表皮生长因子受体突变的晚期非小细胞肺癌患者胸腺素结合的疗效和安全性
7. Activity of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Patients with Non-small Cell Lung Cancer Harboring Rare Epidermal Growth Factor Receptor Mutations [O] . De Pas Tommaso, Toffalorio Francesca, Manzotti Michela, 2011

机译：具有罕见表皮生长因子受体突变的非小细胞肺癌患者中表皮生长因子受体酪氨酸激酶抑制剂的活性

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors vs Conventional Chemotherapy in Non–Small Cell Lung Cancer Harboring Wild-Type Epidermal Growth Factor Receptor

著录项

引文网络

相似文献

相关主题

期刊订阅